CLPTM1 Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-62519r-100uL |
| Product Name | CLPTM1 Recombinant Antibody |
| Applications |
WB
IHC-P
IHC-F
IF
FLOW-CYT
ICC/IF
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human Putative lipid scramblase CLPTM1 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 1209 |
| Swiss Prot | O96005 |
| Synonyms | HS9; N14. |
| Background | Involved in GABAergic but not glutamatergic transmission. Binds and traps GABAA receptors in the endoplasmic reticulum (ER). Modulates postsynaptic GABAergic transmission, and therefore inhibitory neurotransmission, by reducing the plasma membrane expression of these receptors. Altered GABAergic signaling is one among many causes of cleft palate. |
| Application Dilution | |
| WB | 1:300-5000 |
| IHC-P | FCM1:20-100 |
| IHC-F | IHC-P1:200-400 |
| IF | IHC-F1:100-500 |
| Flow-Cyt | IFICC1:50-200 |
| ICC/IF | IF |
Frequently asked questions
Which applications is CLPTM1 Recombinant Antibody (bsm-62519R) validated for, and at what dilution?
bsm-62519R is validated for WB (1:300-5000); FCM (1:20-100); IHC-P (1:200-400); IHC-F (1:100-500); IF(ICC) (1:50-200); IF. These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does CLPTM1 Recombinant Antibody (bsm-62519R) react with?
Tested reactivity: Human.
How should bsm-62519R be stored?
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
What immunogen was used to raise CLPTM1 Recombinant Antibody (bsm-62519R)?
KLH conjugated synthetic peptide derived from human Putative lipid scramblase CLPTM1
